In addition, our study also found that the indexes of CD3+CD4+, CD3+CD56+ and CD3+CD4+/CD3+CD8+ in the two groups were significantly increased, indicating that the immune cell activity of patients was constantly improved, which was related to the decrease of malignant tumor cells, thus confirming the effectiveness of the two treatment plans. Here, CD8A is linked to cancer.